-
1
-
-
84925284879
-
Diagnosis and management of neuropathic pain: Review of literature and recommendations of the Polish Association for the Study of Pain and the Polish Neurological Society - Part Two
-
A. Szczudlik, J. Dobrogowski, J. Wordliczek, and et al. Diagnosis and management of neuropathic pain: review of literature and recommendations of the Polish Association for the Study of Pain and the Polish Neurological Society - Part Two Neurol Neurochir Pol 48 2014 423 435
-
(2014)
Neurol Neurochir Pol
, vol.48
, pp. 423-435
-
-
Szczudlik, A.1
Dobrogowski, J.2
Wordliczek, J.3
-
2
-
-
84883297803
-
Clinical assessment of patients with orofacial pain and temporomandibular disorders
-
I. Stern, and M.S. Greenberg Clinical assessment of patients with orofacial pain and temporomandibular disorders Dent Clin North Am 57 2013 393 404
-
(2013)
Dent Clin North Am
, vol.57
, pp. 393-404
-
-
Stern, I.1
Greenberg, M.S.2
-
4
-
-
84857234795
-
Neurotherapeutics to inhibit exocytosis from sensory neurons for the control of chronic pain
-
J.O. Dolly, and M.A. O'Connell Neurotherapeutics to inhibit exocytosis from sensory neurons for the control of chronic pain Curr Opin Pharmacol 12 2012 100 108
-
(2012)
Curr Opin Pharmacol
, vol.12
, pp. 100-108
-
-
Dolly, J.O.1
O'Connell, M.A.2
-
5
-
-
68549101842
-
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: Explanation and elaboration
-
A. Liberati, D.G. Altman, J. Tetzlaff, and et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration BMJ 339 2009 b2700
-
(2009)
BMJ
, vol.339
, pp. b2700
-
-
Liberati, A.1
Altman, D.G.2
Tetzlaff, J.3
-
7
-
-
84885045036
-
Acute treatment of trigeminal neuralgia with onabotulinum toxin A
-
C. Zúñiga, F. Piedimonte, S. Díaz, and F. Micheli Acute treatment of trigeminal neuralgia with onabotulinum toxin A Clin Neuropharmacol 36 2013 146 150
-
(2013)
Clin Neuropharmacol
, vol.36
, pp. 146-150
-
-
Zúñiga, C.1
Piedimonte, F.2
Díaz, S.3
Micheli, F.4
-
8
-
-
41049093347
-
The combination of estimated from different experiments
-
W.G. Cochran The combination of estimated from different experiments Biomimetrics 10 1954 101 129
-
(1954)
Biomimetrics
, vol.10
, pp. 101-129
-
-
Cochran, W.G.1
-
9
-
-
0037098199
-
Quantifying heterogeneity in a meta-analysis
-
J.P.T. Higgins, and S.G. Thompson Quantifying heterogeneity in a meta-analysis Stat Med 21 2002 1539 1558
-
(2002)
Stat Med
, vol.21
, pp. 1539-1558
-
-
Higgins, J.P.T.1
Thompson, S.G.2
-
10
-
-
84888005745
-
Botulinum toxin A in postherpetic neuralgia: A parallel, randomized, double-blind, single-dose, placebo-controlled trial
-
Z. Apalla, E. Sotiriou, A. Lallas, E. Lazaridou, and D. Ioannides Botulinum toxin A in postherpetic neuralgia: a parallel, randomized, double-blind, single-dose, placebo-controlled trial Clin J Pain 29 2013 857 864
-
(2013)
Clin J Pain
, vol.29
, pp. 857-864
-
-
Apalla, Z.1
Sotiriou, E.2
Lallas, A.3
Lazaridou, E.4
Ioannides, D.5
-
11
-
-
78650096617
-
Subcutaneous injection of botulinum toxin a is beneficial in postherpetic neuralgia
-
L. Xiao, S. Mackey, H. Hui, D. Xong, Q. Zhang, and D. Zhang Subcutaneous injection of botulinum toxin a is beneficial in postherpetic neuralgia Pain Med 11 2010 1827 1833
-
(2010)
Pain Med
, vol.11
, pp. 1827-1833
-
-
Xiao, L.1
Mackey, S.2
Hui, H.3
Xong, D.4
Zhang, Q.5
Zhang, D.6
-
12
-
-
84861800887
-
Botulinum toxin type A for the treatment of trigeminal neuralgia: Results from a randomized, double-blind, placebo-controlled trial
-
C.J. Wu, Y.J. Lian, Y.K. Zheng, and et al. Botulinum toxin type A for the treatment of trigeminal neuralgia: results from a randomized, double-blind, placebo-controlled trial Cephalalgia 32 2012 443 450
-
(2012)
Cephalalgia
, vol.32
, pp. 443-450
-
-
Wu, C.J.1
Lian, Y.J.2
Zheng, Y.K.3
-
13
-
-
84919926818
-
Two doses of botulinum toxin type A for the treatment of trigeminal neuralgia: Observation of therapeutic effect from a randomized, double-blind, placebo-controlled trial
-
H. Zhang, Y. Lian, Y. Ma, and et al. Two doses of botulinum toxin type A for the treatment of trigeminal neuralgia: observation of therapeutic effect from a randomized, double-blind, placebo-controlled trial J Headache Pain 15 2014 65
-
(2014)
J Headache Pain
, vol.15
, pp. 65
-
-
Zhang, H.1
Lian, Y.2
Ma, Y.3
-
14
-
-
84900259205
-
Botulinum toxin-type A: Could it be an effective treatment option in intractable trigeminal neuralgia?
-
H.S. Shehata, M.S. El-Tamawy, N.M. Shalaby, and G. Ramzy Botulinum toxin-type A: could it be an effective treatment option in intractable trigeminal neuralgia? J Headache Pain 14 2013 92
-
(2013)
J Headache Pain
, vol.14
, pp. 92
-
-
Shehata, H.S.1
El-Tamawy, M.S.2
Shalaby, N.M.3
Ramzy, G.4
-
15
-
-
84901325704
-
Therapeutic efficacy and safety of botulinum toxin type A in trigeminal neuralgia: A systematic review
-
Y. Hu, X. Guan, L. Fan, and et al. Therapeutic efficacy and safety of botulinum toxin type A in trigeminal neuralgia: a systematic review J Headache Pain 14 2013 72
-
(2013)
J Headache Pain
, vol.14
, pp. 72
-
-
Hu, Y.1
Guan, X.2
Fan, L.3
-
16
-
-
84892910373
-
A new treatment paradigm for trigeminal neuralgia using Botulinum toxin type A
-
E. Guardiani, B. Sadoughi, A. Blitzer, and D. Sirois A new treatment paradigm for trigeminal neuralgia using Botulinum toxin type A Laryngoscope 124 2014 413 417
-
(2014)
Laryngoscope
, vol.124
, pp. 413-417
-
-
Guardiani, E.1
Sadoughi, B.2
Blitzer, A.3
Sirois, D.4
-
18
-
-
0036840028
-
A focused review on the use of botulinum toxins for neurpathic pain
-
C. Argoff A focused review on the use of botulinum toxins for neurpathic pain Clin J Pain 18 2002 S177 S181
-
(2002)
Clin J Pain
, vol.18
, pp. S177-S181
-
-
Argoff, C.1
-
19
-
-
78650085375
-
The emerging use of botulinum toxins for the treatment of neuropathic pain
-
C. Argoff The emerging use of botulinum toxins for the treatment of neuropathic pain Pain Med 11 2010 1750 1752
-
(2010)
Pain Med
, vol.11
, pp. 1750-1752
-
-
Argoff, C.1
-
20
-
-
80052720881
-
Review of current guidelines on the care of postherpetic neuralgia
-
C. Argoff Review of current guidelines on the care of postherpetic neuralgia Postgrad Med 123 2011 134 142
-
(2011)
Postgrad Med
, vol.123
, pp. 134-142
-
-
Argoff, C.1
-
21
-
-
54849435847
-
Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain
-
D. Ranoux, N. Attal, F. Morain, and D. Bouhassira Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain Ann Neurol 64 2008 274 283
-
(2008)
Ann Neurol
, vol.64
, pp. 274-283
-
-
Ranoux, D.1
Attal, N.2
Morain, F.3
Bouhassira, D.4
-
22
-
-
84866924903
-
Do botulinum toxins have a role in the management of neuropathic pain?: A focused review
-
G.E. Francisco, H. Tan, and M. Green Do botulinum toxins have a role in the management of neuropathic pain?: a focused review Am J Phys Med Rehabil 91 2012 899 909
-
(2012)
Am J Phys Med Rehabil
, vol.91
, pp. 899-909
-
-
Francisco, G.E.1
Tan, H.2
Green, M.3
|